{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:32:48Z","timestamp":1793309568676,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201800001I"],"award-info":[{"award-number":["HHSN275201800001I"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011866","name":"Colorado Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["UM1TR004399"],"award-info":[{"award-number":["UM1TR004399"]}],"id":[{"id":"10.13039\/100011866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["UM1AI068616"],"award-info":[{"award-number":["UM1AI068616"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["UM1AI068632"],"award-info":[{"award-number":["UM1AI068632"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["UM1AI106716"],"award-info":[{"award-number":["UM1AI106716"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009508","name":"Skaggs School of Pharmacy and Pharmaceutical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017973","name":"International Maternal Pediatric Adolescent AIDS Clinical Trials Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jpba.2026.117728","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:40:22Z","timestamp":1789688422000},"page":"117728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of an intracellular LC-MS\/MS assay for the determination of carbovir-triphosphate and remdesivir-triphosphate in peripheral blood mononuclear cells and dried blood spots"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6426-4164","authenticated-orcid":false,"given":"Stefanie K.","family":"Schwab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lane R.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7020","authenticated-orcid":false,"given":"Ryan P.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas A.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3832-8699","authenticated-orcid":false,"given":"Kristina M.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117728_bib1","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents, Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, in: Department of Health and Human Services (Ed.) 2024."},{"issue":"1","key":"10.1016\/j.jpba.2026.117728_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cld.728","article-title":"Update on prevention, diagnosis, and treatment of chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance","volume":"12","author":"Terrault","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jpba.2026.117728_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection","author":"Bhattacharya","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jpba.2026.117728_bib4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/v17081064","article-title":"SARS-CoV-2 infection and antiviral strategies: advances and limitations","volume":"17","author":"Soares","year":"2025","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.jpba.2026.117728_bib5","first-page":"411","article-title":"Nucleotide reverse transcriptase inhibitors: a thorough review, present status and future perspective as HIV therapeutics","volume":"15","author":"Holec","year":"2017","journal-title":"Curr. HIV Res."},{"issue":"1","key":"10.1016\/j.jpba.2026.117728_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14372","article-title":"Current insights and molecular docking studies of HIV-1 reverse transcriptase inhibitors","volume":"103","author":"Singh","year":"2024","journal-title":"Chem. Biol. Drug. Des."},{"issue":"2","key":"10.1016\/j.jpba.2026.117728_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkq447","article-title":"Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection","volume":"66","author":"Anderson","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"issue":"15","key":"10.1016\/j.jpba.2026.117728_bib8","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/QAD.0000000000003062","article-title":"Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine\/ tenofovir alafenamide vs. emtricitabine\/ tenofovir disoproxil fumarate","volume":"35","author":"Yager","year":"2021","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.jpba.2026.117728_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01710-17","article-title":"Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy","volume":"62","author":"Anderson","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.jpba.2026.117728_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000002354","article-title":"Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: The TAF-DBS Study","volume":"84","author":"Yager","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.jpba.2026.117728_bib11","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1089\/aid.2013.0044","article-title":"Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue","volume":"29","author":"Louissaint","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"1","key":"10.1016\/j.jpba.2026.117728_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/11318110-000000000-00000","article-title":"Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action","volume":"49","author":"Bazzoli","year":"2010","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.jpba.2026.117728_bib13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/381678","article-title":"The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities","volume":"38","author":"Anderson","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jpba.2026.117728_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/135965350901400203","article-title":"A new era of antiretroviral drug toxicity","volume":"14","author":"Calmy","year":"2009","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.jpba.2026.117728_bib15","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/dmd.122.000856","article-title":"Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine","volume":"51","author":"To","year":"2023","journal-title":"Drug. Metab. Dispos."},{"issue":"2","key":"10.1016\/j.jpba.2026.117728_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2011.05.039","article-title":"Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS\/MS detection","volume":"56","author":"Bushman","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117728_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","article-title":"Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots","volume":"122","author":"Zheng","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117728_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpba.2013.08.033","article-title":"Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS\/MS","volume":"88","author":"Zheng","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2026.117728_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/aid.2023.0059","article-title":"Intracellular Islatravir-Triphosphate in Dried Blood Spots and Peripheral Blood Mononuclear Cells from Pig-Tailed Macaques","volume":"40","author":"Mainella","year":"2024","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jpba.2026.117728_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchromb.2013.10.035","article-title":"Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry","volume":"944","author":"Jimmerson","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2026.117728_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jchromb.2014.11.032","article-title":"Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS\/MS quantification","volume":"978-979","author":"Jimmerson","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"12","key":"10.1016\/j.jpba.2026.117728_bib22","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1128\/AAC.01693-15","article-title":"Validation and Application of a Liquid Chromatography-Tandem Mass Spectrometry Method To Determine the Concentrations of Sofosbuvir Anabolites in Cells","volume":"59","author":"Rower","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2026.117728_bib23","unstructured":"Aurobindo Pharma Limited, Abacavir, 2018."},{"key":"10.1016\/j.jpba.2026.117728_bib24","unstructured":"Gilead Sciences Inc., Veklury, 2020."},{"issue":"5","key":"10.1016\/j.jpba.2026.117728_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"8","key":"10.1016\/j.jpba.2026.117728_bib26","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1016\/S2352-3018(23)00107-8","article-title":"Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study","volume":"10","author":"Brooks","year":"2023","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.jpba.2026.117728_bib27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/jiae298","article-title":"Pharmacokinetics and Safety of Remdesivir in Pregnant and Nonpregnant Women With COVID-19: Results From IMPAACT 2032","volume":"230","author":"Brooks","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"S1","key":"10.1016\/j.jpba.2026.117728_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bcp.16286","article-title":"Cellular pharmacology of NRTI anabolites in PBMCS and platelets among persons with HIV receiving ABC\/3TC- or TAF\/FTC-based ART","volume":"90","author":"Schwab","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"S1","key":"10.1016\/j.jpba.2026.117728_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bcp.70217","article-title":"Intracellular carbovir- and lamivudine-triphosphate concentrations in PBMC and DBS among children with HIV-1 receiving ABC\/DTG\/3TC: Results from IMPAACT 2019","volume":"91","author":"Schwab","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.jpba.2026.117728_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf177","article-title":"Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort","volume":"12","author":"Davies Smith","year":"2025","journal-title":"Open. Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.jpba.2026.117728_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jpba.2026.117728_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159090","article-title":"Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease","volume":"7","author":"Cross","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jpba.2026.117728_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0659","article-title":"The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection","volume":"11","author":"Woolsey","year":"2025","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.jpba.2026.117728_bib34","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41591-025-03496-y","article-title":"Oral obeldesivir provides postexposure protection against Marburg virus in nonhuman primates","volume":"31","author":"Cross","year":"2025","journal-title":"Nat. Med."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:24:42Z","timestamp":1793309082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526003961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":34,"alternative-id":["S0731708526003961"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117728","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of an intracellular LC-MS\/MS assay for the determination of carbovir-triphosphate and remdesivir-triphosphate in peripheral blood mononuclear cells and dried blood spots","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117728"}}